AP@home

| News

AP@home is an FP7 funded project and Triteq are one of twelve companies involved across Europe. The objective of AP@home is to build and evaluate an artificial pancreas (AP) with automated closed loop glycaemic control for insulin treated patients with diabetes.

AP systems require algorithms using blood glucose levels obtained via glucose monitoring for controlling subcutaneous insulin administration.

The project is in its second year and would like to announce the launch of their new AP@home Internet website. Please take a look at www.apathome.eu.

Leave a Reply

Your email address will not be published. Required fields are marked *

product design & development for:

Siemens gets CE-Mark for new diagnostic solution

Siemens Healthineers has received CE-Mark for its new Atellica Solution with immunoassay and chemistry analysers, which will allow commercial launch in Europe. The flexible, scalable, automation-ready in-vitro diagnostic (IVD) solution is designed to provide control and simplicity to diagnostic professionals,… more

Synaptive Medical introduces new surgical robotic device

Canadian firm Synaptive Medical has introduced its second-generation, high-powered Modus V digital microscope that has a robotic arm to aid neurosurgery. Modus V is based on Canadarm technology used at the International Space Station and is part of the firm’s… more